Skip to main content
Emily Slotkin, MD, Pediatric Hematology & Oncology, New York, NY

Emily Slotkin MD

Pediatric Sarcoma Oncology


Physician

Request Appointment
  • 1275 York AvenueNew York, NY 10065

  • Book by Phone+1(980) 377-2752

Overview of  Dr. Slotkin

Dr. Emily Slotkin is a pediatric hematologist and oncologist based in New York, NY, with subspecialty in pediatric sarcoma oncology. She completed her residency in Pediatrics at the Jacobi Medical Center/Albert Einstein College of Medicine and further pursued her Fellowship in Pediatric Hematology/Oncology at New York Presbyterian Hospital (Cornell Campus). She is known for her numerous publications in respected journals such as Cancer Research, European Journal of Cancer, and Clinical Cancer Research, some of which have been cited by other publications. Dr. Slotkin is involved in several clinical trials as a contact or principal investigator, including studies involving patients with solid tumors and Ewing sarcoma among others.

Education & Training

  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2008 - 2011
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2008
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2011 - 2028
  • NJ State Medical License
    NJ State Medical License 2024 - 2027
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to Clinical Trials?
    Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to Clinical Trials?December 9th, 2022
  • MSK Research Highlights, April 27, 2026
    MSK Research Highlights, April 27, 2026April 28th, 2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: